Using a Supraglottic Airway for Positive Pressure Ventilation in Premature Infants Born Between 29 and 34 Weeks A Pilot Study on Delivery Room Resuscitation Feasibility

What this Trial Is About

Researchers are studying whether using a supraglottic airway as the main tool for providing positive pressure ventilation PPV is workable and effective during delivery room resuscitation of premature infants born between 29 07 and 33 67 weeks of gestation. This trial focuses on understanding if this airway device can be used successfully in the critical moments after birth to support breathing in these fragile newborns. In this single-group study, premature infants who need PPV right after birth will receive ventilation through a supraglottic airway as the primary interface during resuscitation. The study involves prenatal screening and obtaining informed consent from the parent before delivery. On the day of birth, infants will be rescreened for eligibility and, if resuscitation is required, the supraglottic airway will be used immediately. Data will be collected during resuscitation and for up to 24 hours afterward. Participants will be closely monitored during and after delivery room resuscitation with data gathered on the ease and timing of airway placement, the duration of airway use, and overall feasibility of this approach within the first 10 minutes of life. Clinical and procedural details will be recorded, and safety observations will continue for up to one day after birth. This study aims to provide detailed information about the use of the supraglottic airway in neonatal resuscitation for these premature infants.

Supraglottic Airway for Resuscitation in Preemies